You are currently viewing a new version of our website. To view the old version click .

Vaccines, Volume 12, Issue 8

August 2024 - 129 articles

Cover Story: Healthcare workers (HCWs) are a high-risk group for hepatitis B virus (HBV) infection. About 5–10% of the general population fails to respond to HBV vaccination. Here, we study the biological age of B cells from HCWs responding (R) or not responding (NR) to the HBV vaccine. We used genome-wide DNA methylation data to estimate a set of biomarkers in 41 Rs and 30 NRs between 22 and 62 years old. Unresponsiveness to HBV vaccination was associated with accelerated epigenetic aging (DNAmAge, AltumAge, DunedinPoAm) and was accompanied by epigenetic drift. Female NRs had higher estimates of telomere length and lower CRP inflammation risk score when compared to Rs. This study demonstrates that several methylation-based clocks and biomarkers are associated with an increased risk of unresponsiveness to HBV vaccination, particularly in females. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (129)

  • Article
  • Open Access
2 Citations
1,547 Views
15 Pages

Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination

  • Eline Meyers,
  • Liselore De Rop,
  • Fien Engels,
  • Claudia Gioveni,
  • Anja Coen,
  • Tine De Burghgraeve,
  • Marina Digregorio,
  • Pauline Van Ngoc,
  • Nele De Clercq and
  • Laëtitia Buret
  • + 10 authors

22 August 2024

When COVID-19 vaccines were implemented, nursing home residents (NHRs) and staff (NHS) in Belgium were prioritized for vaccination. To characterize the vaccine response over time in this population and to identify poorly responding groups, we assesse...

  • Review
  • Open Access
19 Citations
6,886 Views
26 Pages

Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective

  • Dequan Liu,
  • Lei Liu,
  • Xinghan Li,
  • Shijin Wang,
  • Guangzhen Wu and
  • Xiangyu Che

22 August 2024

With the continuous advancements in tumor immunotherapy, researchers are actively exploring new treatment methods. Peptide therapeutic cancer vaccines have garnered significant attention for their potential in improving patient outcomes. Despite its...

  • Article
  • Open Access
5 Citations
4,475 Views
14 Pages

Tracking Measles and Rubella Elimination Progress—World Health Organization African Region, 2022–2023

  • Balcha G. Masresha,
  • Charles Shey Wiysonge,
  • Reggis Katsande,
  • Patrick Michael O’Connor,
  • Emmaculate Lebo and
  • Robert T. Perry

22 August 2024

Measles or rubella elimination is verified when endemic transmission of the corresponding virus has been absent for over 36 months in a defined area, in the presence of a well-performing surveillance system. This report updates the progress by 47 cou...

  • Article
  • Open Access
2 Citations
2,276 Views
16 Pages

Development of a Ferritin-Based Nanoparticle Vaccine against Classical Swine Fever

  • Yiwan Song,
  • Zhongmao Yuan,
  • Junzhi Ji,
  • Yang Ruan,
  • Xiaowen Li,
  • Lianxiang Wang,
  • Weijun Zeng,
  • Keke Wu,
  • Wenshuo Hu and
  • Lin Yi
  • + 5 authors

22 August 2024

The occurrence of classical swine fever (CSF) poses a significant threat to the global swine industry. Developing an effective and safe vaccine is crucial for preventing and controlling CSF. Here, we constructed self-assembled ferritin nanoparticles...

  • Article
  • Open Access
7 Citations
2,953 Views
13 Pages

Global Status Report for the Verification of Measles and Rubella Elimination, 2022

  • Patrick O’Connor,
  • Balcha Masresha,
  • Desirée Pastor,
  • Nasrin Musa,
  • José Hagan,
  • Sudhir Khanal,
  • Chung-Won Lee and
  • Natasha Crowcroft

22 August 2024

Since the World Health Assembly (WHA) in 2012 endorsed the Global Vaccine Action Plan (GVAP), which included regional measles and rubella elimination goals by 2020, global progress towards verification of measles and rubella elimination has been incr...

  • Article
  • Open Access
5 Citations
3,942 Views
13 Pages

The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance

  • Paul A. Rota,
  • Roger Evans,
  • Myriam Corinne Ben Mamou,
  • Gloria Rey-Benito,
  • Lucky Sangal,
  • Annick Dosseh,
  • Amany Ghoniem,
  • Charles R. Byabamazima,
  • Maurice Demanou and
  • Raydel Anderson
  • + 10 authors

22 August 2024

With 762 laboratories, the Global Measles and Rubella Laboratory Network (GMRLN) is the largest laboratory network coordinated by the World Health Organization (WHO). Like the Global Polio Laboratory Network, the GMRLN has multiple tiers, including g...

  • Article
  • Open Access
1 Citations
2,578 Views
12 Pages

Hesitancy toward Childhood and Influenza Vaccines: Experiences from Highly Educated Jordanian Parents

  • Montaha Al-Iede,
  • Mohammad Aljahalin,
  • Eva Fashho,
  • Sami Sweis,
  • Rahaf Mesmeh,
  • Loai Bani Hamad,
  • Leen Abuzaid,
  • Jana Al Sa’ed,
  • Yasmeen Elbetar and
  • Aya Yaseen Mahmood Alabdali
  • + 2 authors

22 August 2024

We aimed to examine vaccine hesitancy and knowledge towards influenza vaccines among Jordanian parents. Data were collected via an online questionnaire distributed between October 2023 and March 2024. They included sections on demographics, parental...

  • Article
  • Open Access
2,278 Views
22 Pages

Viral Vector-Based Chlamydia trachomatis Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice

  • Giuseppe Andreacchio,
  • Ylenia Longo,
  • Sara Moreno Mascaraque,
  • Kartikan Anandasothy,
  • Sarah Tofan,
  • Esma Özün,
  • Lena Wilschrey,
  • Johannes Ptok,
  • Dung T. Huynh and
  • Joen Luirink
  • + 1 author

22 August 2024

Chlamydia trachomatis remains a major global health problem with increasing infection rates, requiring innovative vaccine solutions. Modified Vaccinia Virus Ankara (MVA) is a well-established, safe and highly immunogenic vaccine vector, making it a p...

  • Article
  • Open Access
2,504 Views
16 Pages

Immunogenicity and Protective Efficacy of Dose-Sparing Epigraph Vaccine against H3 Swine Influenza A Virus

  • Erika Petro-Turnquist,
  • Adthakorn Madapong,
  • David Steffen and
  • Eric A. Weaver

22 August 2024

Swine influenza A virus (IAV-S) is a highly prevalent and transmissible pathogen infecting worldwide swine populations. Our previous work has shown that the computationally derived vaccine platform, Epigraph, can induce broadly cross-reactive and dur...

  • Review
  • Open Access
13 Citations
8,211 Views
33 Pages

22 August 2024

Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most important pathogens in pig production worldwide and responsible for enormous production and economic losses. PRRSV infection in gestating gilts and sows induces important...

of 13

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393XCreative Common CC BY license